December 10, 2007 - INNOVIVE Pharmaceuticals Presents Phase I Data on INNO-406 for Treatment of Gleevec-resistant or Intolerant Chronic Myelogenous Leukemia at ASH

December 8, 2007 - INNOVIVE Pharmaceuticals Presents Preliminary Data at ASH Showing INNO-305 Elicits Immune Response in Patients with Myeloid and Thoracic Neoplasms

December 5, 2007 - Data from INNOVIVE Pharmaceuticals’ Oncology Drug Programs to be Presented at the American Society of Hematology 49th Annual Meeting

November 15, 2007 - INNOVIVE Pharmaceuticals Initiates Pivotal Phase II Clinical Trial with Tamibarotene

November 14, 2007 - INNOVIVE Pharmaceuticals Announces Third Quarter 2007